Related Experiment Videos
On the identification and frequency of the J and K cholinesterase phenotypes in a Caucasian population
Insights
This study identified specific cholinesterase genotypes (E1aE1j and E1aE1k) in Caucasian patients, increasing their risk of sensitivity to suxamethonium. These findings help explain unexplained low cholinesterase activity.
Area of Science:
- Biochemistry
- Human Genetics
- Pharmacogenetics
Background:
- Cholinesterase activity is crucial for drug metabolism, particularly for neuromuscular blocking agents.
- Genetic variations in cholinesterase enzymes can lead to altered drug responses.
- Suxamethonium sensitivity is a known clinical concern linked to specific enzyme variants.
Purpose of the Study:
- To analyze cholinesterase genotypes in a Caucasian patient cohort.
- To identify individuals at increased risk of suxamethonium sensitivity.
- To report characteristic inhibitor numbers for specific genotypes.
Main Methods:
- Analysis of cholinesterase status in 795 Caucasian patients.
- Genotyping to identify E1aE1j and E1aE1k variants.
- Quantification of enzyme activity and inhibitor numbers.
Main Results:
- Identified E1aE1j genotype in 0.4% and E1aE1k in 2.8% of patients.
- Both genotypes are associated with increased suxamethonium sensitivity.
- Reported inhibitor numbers specific to these genotypes.
- Estimated that 1 in 76 individuals could be a KK homozygote.
Conclusions:
- The identified genotypes (E1aE1j, E1aE1k) are clinically significant due to suxamethonium sensitivity risk.
- The findings offer a potential explanation for unexplained low cholinesterase activity.
- The reported data can aid in easier identification of these genotypes by researchers.
Abstract:
An analysis of investigations performed between December 1978 and September 1982 into the cholinesterase status of 795 Caucasian patients has revealed an E1aE1j genotype in three (0.4%) and an E1aE1k genotype in 22 (2.8%). Both groups of patients are at increased risk of sensitivity to suxamethonium. Inhibitor numbers characteristic of these genotypes are reported which it is hoped will assist other workers to identify them more easily. While the J allele is probably rare among the general population it is suggested that as many as one person in 76 could be a KK homozygote. Our findings provide a possible explanation of the low cholinesterase activities seen in some patients for which there is no other obvious cause.